USA: 
Europe: 
Email: 
Consultation
| Catalog: | C1285T |
| Product Type: | Test kit |
| Unit: | 96 tests |
| Assay time: | 3.5 hours |
| Limit of detection: | 0.4 ng/ml |
| Sample type: | Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate |
| Sample requirements: | 5 µl/well |
| Analysis mode: | Sandwich ELISA |
| Species specificity: | Human |
| Storage: | 2–8°C |
| Application: | Atherosclerosis, Bone and cartilage metabolism, Cardiovascular disease, Extracellular matrix, Pulmonary diseases |
There is evidence that Cartilage oligomeric matrix protein (COMP) is essential for maintaining vascular homeostasis, and is an endogenous thrombin inhibitor and negative regulator of hemostasis and thrombosis. Research suggests a pathogenetic role of COMP the development of vascular fibrosis and calcification, and thus COMP may be a novel target in therapy of a number of vascular diseases.
Diagnostic Development
Follow Us -
Copyright © 2024 Creative Bioarray. All rights reserved.
